Can-Fite BioPharma (CANF) Return on Sales [ROS] (2015 - 2023)
Can-Fite BioPharma's Return on Sales [ROS] was -2456.79% in FY2025, down 1250.56 percentage points from -1206.23% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Return on Sales [ROS] (2015 - 2023) Analysis & Trends
From FY2015 onward, Can-Fite BioPharma has reported Return on Sales [ROS] for 11 years.
- Return on Sales [ROS] shows a five-year change of -603.71 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Return on Sales [ROS] in data going back to FY2015.
- Per Business Quant data, Return on Sales [ROS] in earlier years was -1206.23% in FY2024 (-103.27 pp), -1102.96% in FY2023 (unchanged), -1102.96% in FY2022 (+402.55 pp) and -1505.51% in FY2021 (+347.57 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1,183.23% |
| Sep 30, 2023 | -951.53% |
| Jun 30, 2023 | -910.20% |
| Mar 31, 2023 | -1,383.67% |
| Dec 31, 2022 | -909.23% |
| Sep 30, 2022 | -1,261.27% |
| Jun 30, 2022 | -1,014.71% |
| Mar 31, 2022 | -1,156.10% |
| Dec 31, 2021 | -1,974.51% |
| Sep 30, 2021 | -1,398.41% |
| Jun 30, 2021 | -1,253.20% |
| Mar 31, 2021 | -1,466.89% |
| Dec 31, 2020 | -2,368.67% |
| Sep 30, 2020 | -1,174.88% |
| Jun 30, 2020 | -1,877.94% |
| Dec 31, 2019 | -2,401.56% |
| Sep 30, 2019 | -242.27% |
| Jun 30, 2019 | -1,623.65% |
| Mar 31, 2019 | 572.24% |
| Dec 31, 2018 | -866.09% |
API Access
Can-Fite BioPharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();